Lopid and Uveitis - a phase IV clinical study of FDA data

Summary:

Uveitis is reported as a side effect among people who take Lopid (gemfibrozil), especially for people who are male, 50-59 old, also take Lipitor, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Uveitis when taking Lopid. It is created by eHealthMe based on reports of 9,538 people who have side effects when taking Lopid from the FDA, and is updated regularly.

What is Lopid?

Lopid has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 9,700 Lopid users. Check the latest studies of Lopid.

What is Uveitis?

Uveitis (inflammation of the uvea) is found to be associated with 831 drugs and 1,528 conditions by eHealthMe. Check the latest studies of Uveitis.



On Jul, 14, 2026

9,538 people reported to have side effects when taking Lopid.
Among them, 12 people (0.13%) have Uveitis.

Could Lopid cause Uveitis?

Among these 12 people:

What is the gender of people who have Uveitis when taking Lopid? *

  • female: 8.33 %
  • male: 91.67 %

What is the age of people who have Uveitis when taking Lopid? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 66.67 %
  • 60+: 33.33 %

What are other drugs people take besides Lopid? *

  1. Lipitor: 10 people, 83.33%
  2. Avandia: 8 people, 66.67%
  3. Zometa: 7 people, 58.33%
  4. Glipizide: 7 people, 58.33%
  5. Lunesta: 7 people, 58.33%
  6. Lorazepam: 7 people, 58.33%
  7. Lisinopril: 7 people, 58.33%
  8. Niacin: 7 people, 58.33%
  9. Niaspan: 7 people, 58.33%
  10. Omeprazole: 7 people, 58.33%

What are other side effects people have besides Uveitis? *

  1. Pain: 8 people, 66.67%
  2. Wheezing (a high-pitched whistling sound made while you breath): 7 people, 58.33%
  3. Oedema Peripheral (superficial swelling): 7 people, 58.33%
  4. Lymphoedema (localized fluid retention and tissue swelling): 7 people, 58.33%
  5. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 7 people, 58.33%
  6. Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 7 people, 58.33%
  7. Kidney Infection (Pyelonephritis): 7 people, 58.33%
  8. Impaired Healing: 7 people, 58.33%
  9. Hepatic Steatosis (fatty liver disease): 7 people, 58.33%
  10. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 7 people, 58.33%

What are the existing conditions these people have? *

  1. Diabetes: 1 person, 8.33%
  2. Chronic Renal Failure (kidney failure): 1 person, 8.33%
  3. Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lopid and have Uveitis?

- Check whether Uveitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lopid:

Uveitis treatments and more:

How severe was Uveitis and when was it recovered:

Expand to all the drugs that have ingredients of gemfibrozil:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lopid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Uveitis:

Browse all the conditions that are associated with Uveitis:


How the study uses the data?

The study uses data from the FDA. It is based on gemfibrozil (the active ingredients of Lopid) and Lopid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: